NGM313, a novel activator of beta- klotho/FGFR1c, improves insulin resistance and reduces hepatic fat in obese, nondiabetic subjects [abstract 140-LB] - Depaoli, A; Phung, V; Bashir, M R (Diabetes, 2019)
et al.